Delayed Prostate Cancer Therapy Wantagh NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Dariush Radparvar
(516) 562-4815
300 Community Dr
Manhasset, NY
HESHAM TAHA, MD
(516) 572-6501
2201 Hempstead Turnpike
East Meadow, NY
EDWARD HALBRIDGE, MD
(516) 488-7111
397 Franklin Avenue
Franklin Square, NY
John Danl Del Rowe, MD
212-920-4140
300 Community Dr
Manhasset, NY
Mary K Smith Ree, MS
18123 Henley Rd
Jamaica, NY
William Piper Reed
(516) 663-3300
120 Mineola Blvd
Mineola, NY
Farida P Chaudhri MD
(718) 358-3057
146-01 45th Ave
Flushing, NY
SCOTT FIELDS, MD
(516) 734-8791
450 Lakeville Road
New Hyde Park, NY
Rene S Mediavillo, MD
718-835-9729
9202 Liberty Ave
Ozone Park, NY
Lihong We, MD
718-460-2300
5916 174th St
Fresh Meadows, NY
Data Provided by:
      

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Head and Neck Cancer Treatment Wantagh NY
Incomplete and interrupted radiation treatment is a common problem among Medicare patients with head and neck cancer, a new study has found. Researchers analyzed data from 5,086 Medicare patients diagnosed with head and neck cancer between 1997 and 2003 and found that nearly 40 percent of them experienced interruptions in radiation therapy or failed to complete the course of therapy.
- Diagnosis of Prostate Cancer Wantagh NY
- Drug Combo Proves Powerful Against Lung Cancer Wantagh NY
- Exercise for Prostate Cancer Wantagh NY
- Open Prostatectomy Versus Laparoscopic Procedure Wantagh NY
- Hormone Therapy for Prostate Cancer Wantagh NY
- Hormone Therapy for Early Prostate Cancer Wantagh NY
- Hormone Therapy for Breast Cancer Wantagh NY
- Hormone Therapy for Lung Cancer Wantagh NY
- Attack Of The Cancer Fighting Tomatoes Wantagh NY